Back to MW MARSHALL WACE, LLP

PLRXPLRX
16 quarters

Position history for MWMARSHALL WACE, LLP's holdings in PLIANT THERAPEUTICS INC

MARSHALL WACE, LLP holds 835,124 shares of PLRX (PLIANT THERAPEUTICS INC), worth $952,041 as of 2026-Q2. The position was decreased (-16.1% shares). PLRX represents 0.0% of MARSHALL WACE, LLP's portfolio.

Current Value

$952,041

Current Shares

835,124

Total Value Change

+$581,041

Total Shares Change

+788,710

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
835,124
-16.1%
$952,0410.0%$1.14
0
2026-Q1
Decreased
995,973
-7.8%
$1.3M0.0%$1.25
0
2025-Q4
Increased
1.1M
+260.7%
$1.3M0.0%$1.21
41
2025-Q3
New
299,461
-
$443,2030.0%$1.49
33
2025-Q2
Exited
0
-100.0%
$00.0%$1.25
0
2025-Q1
Increased
208,532
+287.0%
$281,5190.0%$1.47
38
2024-Q4
New
53,880
-
$709,6010.0%$12.79
34
2024-Q2
Exited
0
-100.0%
$00.0%$10.75
0
2024-Q1
New
130,935
-
$2M0.0%$14.90
36
2023-Q4
Exited
0
-100.0%
$00.0%$18.11
0
2023-Q3
New
73,921
-
$1.3M0.0%$17.34
35
2023-Q2
Exited
0
-100.0%
$00.0%$18.26
0
2023-Q1
Decreased
37,354
-43.3%
$993,6160.0%$26.54
0
2022-Q4
New
65,820
-
$1.3M0.0%$19.33
35
2022-Q3
Exited
0
-100.0%
$00.0%$20.76
0
2022-Q2
New
46,414
-
$371,0000.0%$7.68
33

Other major holders of PLRX: BlackRock Finance, Inc., PRICE T ROWE ASSOCIATES INC /MD/, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used